GreatNorthCollective/greatnorth-canada-federal-laws-text huggingface dataset:
Benzodiazepines and Other Targeted Substances Regulations — 45
Annual report 45 (1) Subject to subsections (2) and (3), a licensed dealer must provide to the Minister, within three months after the end of each calendar year, an annual report that contains (a) the specified name, the form and the total quantity of each targeted substance that they receive, produce, assemble, sell, provide, import, export or destroy during the calendar year, as well as the name and total quantity of each targeted substance that they use to manufacture or assemble a product or compound; (b) the specified name, the form and the quantity of each targeted substance in physical inventory taken at the site specified in their licence at the end of the calendar year; and (c) the specified name, the form and the quantity of any targeted substance that has been lost or stolen in the course of conducting activities during the calendar year. Non-renewal or revocation within first three months (2) If a licensed dealer’s licence expires without being renewed or is revoked during the first three months of a calendar year, the dealer must provide to the Minister (a) within three months after the end of the preceding calendar year, the annual report in respect of that year; and (b) within three months after the expiry or revocation, a report in respect of the portion of the current calendar year during which the licence was valid that contains the information referred to in subsection (1), in which the quantity in physical inventory is to be calculated as of the date of expiry or revocation. Non-renewal or revocation after third month (3) If a licensed dealer’s licence expires without being renewed or is revoked after the first three months of a calendar year, the dealer must provide to the Minister, within three months after the expiry or revocation, a report in respect of the portion of the calendar year during which the licence was valid that contains the information referred to in subsection (1) for that period, in which the quantity in physical inventory is to be calculated as of the date of expiry or revocation. SOR/2019-170, s. 2
Benzodiazepines and Other Targeted Substances Regulations — 48
Application 48 Sections 49 to 56 do not apply to a pharmacist when they are practising in a hospital. SOR/2014-260, s. 34(F) SOR/2019-170, s. 4
Benzodiazepines and Other Targeted Substances Regulations — 49
Authorization 49 A pharmacist may, in accordance with sections 50 to 57, compound a targeted substance in accordance with a prescription. SOR/2019-170, s. 4
Benzodiazepines and Other Targeted Substances Regulations — 50
Record of receipt from licensed dealer 50 If a pharmacist receives a targeted substance from a licensed dealer, a pharmacist in another pharmacy or a hospital, the pharmacist must keep a record of the following information: (a) the brand name of the targeted substance received or, if the targeted substance does not have a brand name, the specified name; (b) the quantity and strength per unit of the targeted substance received, the number of units per package and the number of packages; (c) the name and address of the licensed dealer, pharmacist or hospital that supplied it; and (d) the date on which it was received. SOR/2014-260, s. 39(F)
Benzodiazepines and Other Targeted Substances Regulations — 51
Prescription required 51 (1) In addition to the activities authorized under section 55, a pharmacist may, subject to section 52, sell, provide, send, deliver or transport a targeted substance to or for an individual or for the benefit of an animal if (a) the pharmacist sells or provides the substance in a container labelled in accordance with subsection (2); (b) the transaction is made pursuant to a prescription (i) dated and signed by a practitioner, (ii) provided verbally to the pharmacist by a practitioner, or (iii) transferred to the pharmacist under subsection 54(1) in accordance with subsection 54(2); (c) the pharmacist has not transferred the prescription to another pharmacist; and (d) when the prescription has been provided verbally, the transaction is recorded by the pharmacist in accordance with subsection (3). Labelling required (2) A pharmacist who sells or provides a targeted substance to an individual must do so in a container that is labelled with the following information: (a) the name and address of the pharmacy or pharmacist; (b) the date of issuance of the prescription and the number given to it by the pharmacist; (c) the name of the individual for whose benefit the targeted substance is sold or provided or, if it is sold or provided for the benefit of an animal, the name of the individual having caring of the animal or the name of the animal; (d) the name of the practitioner who issued the prescription; (e) the specified name or brand name of the targeted substance; (f) the quantity and, if applicable, the strength per unit of the targeted substance; and (g) the directions for use specified by the practitioner. Record of verbal prescription (3) A pharmacist who receives a verbal prescription for a targeted substance must, before filling it, (a) record the following information: (i) the name and address of the individual for whose benefit the prescription is provided or, if it is provided for the benefit of an animal, the name and address of the individual having caring of the animal and, if applicable, the name of the animal, (ii) the date that the verbal prescription was provided, (iii) the specified name or brand name of the targeted substance, as specified in the prescription, (iv) the quantity and, if applicable, the strength per unit of the targeted substance, (v) the name of the recording pharmacist and the name of the practitioner who issued the prescription, (vi) the directions for use specified by the practitioner, and (vii) if the prescription is to be refilled, the number of times it may be refilled and, if specified, the interval between refills; and (b) keep a hard copy or create a written record of the prescription. SOR/2010-223, s. 24 SOR/2019-170, s. 5
Benzodiazepines and Other Targeted Substances Regulations — 52
Refills 52 A pharmacist may only refill a prescription for a targeted substance if (a) the practitioner who prescribed it expressly directs that the prescription may be refilled and specifies the number of refills; (b) the pharmacist makes a record of each refill in accordance with section 53; (c) less than one year has elapsed since the day on which the prescription was issued by the practitioner; (d) at least one refill remains on the prescription; and (e) in the case where an interval between refills has been specified by the practitioner, it has expired.
Benzodiazepines and Other Targeted Substances Regulations — 53
Records 53 A pharmacist who fills or refills a prescription for a targeted substance must record the following information: (a) the date the prescription was filled or refilled; (b) the quantity of the targeted substance provided at the original filling and at each refill; (c) the pharmacist’s name or initials; and (d) the number assigned to the prescription.
Benzodiazepines and Other Targeted Substances Regulations — 54
Transfer of prescription 54 (1) A pharmacist may transfer a prescription for a targeted substance to another pharmacist, except a prescription that has already been transferred. Additional information (2) Before a pharmacist sells or provides a targeted substance to an individual under a prescription transferred under subsection (1), the pharmacist must (a) in the case of a verbal transfer, record the information required by subsection 51(3); (b) in the case of a written transfer, have obtained from the transferring pharmacist a copy of (i) the prescription written by the practitioner, or (ii) the record made in accordance with subsection 51(3) of the practitioner’s verbal prescription; and (c) in all cases, record (i) the name and address of the transferring pharmacist, (ii) the number of authorized refills remaining and, if applicable, the specified interval between refills, and (iii) the date of the last refill. Records — transferring pharmacist (3) A pharmacist who transfers a prescription under subsection (1) must record the date of the transfer, the name of the pharmacist to whom the prescription was transferred, the name and address of the pharmacy where that pharmacist practises and, if applicable, the number of refills that are being transferred. SOR/2014-260, s. 35(F)
Benzodiazepines and Other Targeted Substances Regulations — 55
Activities without a prescription 55 (1) A pharmacist may sell, provide, send, deliver or transport a targeted substance without a prescription to any of the following persons on receipt of an order from that person that specifies the name and quantity of the targeted substance: (a) if the order is written, a licensed dealer who (i) sold or provided the targeted substance, or (ii) is licensed to destroy targeted substances, other than those that the licensed dealer produced, made, assembled, sold or provided; (b) subject to subsection (2), (i) a practitioner, (ii) another pharmacist, if the other pharmacist states that the targeted substance is required because of a delay or shortfall in an order for the targeted substance placed with a licensed dealer, or (iii) a hospital, if the order is placed by a pharmacist practising in the hospital or by a practitioner who is authorized to order the targeted substance on behalf of the hospital; (c) the Minister, if the order is a written order signed on the Minister’s behalf; or (d) a person to whom an exemption with respect to the targeted substance has been granted under section 56 of the Act, if the order is a written order and is accompanied by a copy of the exemption. Verbal orders (2) In the circumstances set out in subparagraphs (1)(b)(i) to (iii), if the order is verbal, the pharmacist must record the following information: (a) the name and address of the pharmacist or practitioner placing the order; (b) if the order was placed on behalf of an establishment, the name and address of the establishment; (c) the date of the order; (d) the specified name or the brand name of the targeted substance ordered, as specified in the order; (e) the quantity and, if applicable, the strength per unit of the targeted substance; and (f) the name of the recording pharmacist. Records (3) A pharmacist who sells, provides, sends, delivers or transports a targeted substance without a prescription must keep a record of the following information: (a) the brand name of the targeted substance or, if the targeted substance does not have a brand name, the specified name; (b) the quantity and strength per unit of the targeted substance; (c) the name and address of the person referred to in subsection (1) to whom the targeted substance was sold, provided, sent, delivered or transported; and (d) the date of the transaction. Copies (4) The pharmacist must keep the written order or, if the order is verbal, must create a hard copy of the order. SOR/2010-223, s. 25 SOR/2019-170, s. 6(F)
Benzodiazepines and Other Targeted Substances Regulations — 56
Change of location 56 A pharmacist who closes premises in which a targeted substance has been stored must, not later than 10 days after the closure, inform the Minister of the date of closure, the location to which the targeted substance was moved and the quantity of the targeted substance that was moved.
Benzodiazepines and Other Targeted Substances Regulations — 57
Renunciation of privileges 57 (1) A pharmacist who does not wish to receive or have possession of targeted substances may make a written request to the Minister to send to licensed dealers and pharmacies a notice, issued under section 79, that states that targeted substances must not be supplied to that pharmacist. Prohibited actions (2) A pharmacist must not, unless their pharmacy has received a retraction issued under section 80, (a) sell or provide a targeted substance to a pharmacist or practitioner named in a notice issued under section 79; or (b) fill a prescription or order for a targeted substance from a practitioner named in a notice issued under section 79.
Benzodiazepines and Other Targeted Substances Regulations — 58
To patients only 58 A practitioner may, with respect to a targeted substance, prescribe it for or administer it to an individual or animal, or sell, provide, send, deliver or transport it to or for an individual or for the benefit of an animal, only if (a) the individual or animal is a patient that the practitioner is treating in their professional capacity; and (b) the targeted substance is required to treat the individual’s or animal’s medical condition. SOR/2010-223, s. 26(F)
Benzodiazepines and Other Targeted Substances Regulations — 59
Emergency supply 59 (1) A practitioner of medicine may store an emergency supply of targeted substances at a remote location where emergency medical treatment is not readily available or in an emergency medical service vehicle, if the practitioner has an agent or mandatary at that location or in the vehicle who will control and administer the targeted substances on behalf of, and under the direction of, the practitioner. Emergency use (2) When aid is being provided to an individual in an emergency, the agent or mandatary of the practitioner of medicine may administer a targeted substance from the emergency supply to the individual if (a) the practitioner of medicine has, by telephone or other means, directed the agent or mandatary to administer the targeted substance; or (b) the agent or mandatary follows written directives provided by the practitioner with respect to the administration of the targeted substance. SOR/2010-223, s. 27; SOR/2018-69, s. 78(E) SOR/2019-170, s. 8(F)
Benzodiazepines and Other Targeted Substances Regulations — 60
Records — practitioner 60 (1) A practitioner must keep the following records: (a) the brand name or, if the targeted substance does not have a brand name, the specified name, the quantity and strength per unit of any targeted substance received from a licensed dealer, pharmacist or hospital and the date on which it is received; (b) the name and address of the licensed dealer, pharmacist or hospital that sold or provided the targeted substance; (c) if a transaction involves a quantity of targeted substance that exceeds five times the usual daily dose for the substance, the name and quantity of the substance prescribed, administered, sold, provided, sent, delivered or transported, the name and address of the recipient and the date of the transaction; and (d) in the case of an emergency supply referred to in subsection 59(1), the name of the administering agent or mandatary, the location of the emergency supply, the name, quantity and strength per unit of each targeted substance, the date of all transactions related to that emergency supply and the name of any individual to whom the targeted substance was administered. Records — agent or mandatary (2) In respect of the administration of a targeted substance from an emergency supply referred to in subsection 59(1), the agent or mandatary of the practitioner must keep the following records: (a) the name, strength per unit and quantity of each targeted substance administered and the date on which it was administered; (b) the name of the individual to whom the targeted substance was administered; and (c) the name of the agent or mandatary of the practitioner who administered the targeted substance. SOR/2010-223, s. 28; SOR/2018-69, s. 78(E)
Benzodiazepines and Other Targeted Substances Regulations — 61
Obligations — agents 61 (1) An agent or mandatary of a practitioner of medicine referred to in subsection 59(1) must (a) take reasonable steps to protect any targeted substance in their possession from loss and theft; and (b) inform the practitioner without delay of any loss or theft of a targeted substance. Obligations — practitioner of medicine (2) A practitioner of medicine who is informed by their agent or mandatary of the loss or theft of a targeted substance must inform the Minister in accordance with subsection 72(2). SOR/2018-69, s. 78(E) SOR/2019-170, s. 9
Benzodiazepines and Other Targeted Substances Regulations — 62
Request for renunciation 62 A practitioner who does not wish to receive or have possession of targeted substances may make a written request to the Minister to send to licensed dealers and pharmacies a notice issued under section 79 that states that (a) recipients of the notice must not sell or provide any targeted substance to that practitioner; and (b) pharmacists practising in the notified pharmacies must not fill a prescription or order for any targeted substance provided by that practitioner. SOR/2010-223, s. 29(E); SOR/2014-260, s. 36(F)
Benzodiazepines and Other Targeted Substances Regulations — 63
Authorization 63 (1) A hospital may, in accordance with subsection (2) and sections 64 to 67, sell, provide, administer, send, deliver or transport a targeted substance. Ordering targeted substances (2) No person may order a targeted substance on behalf of a hospital other than a pharmacist or practitioner practising in the hospital who is authorized by the person in charge of the hospital to order targeted substances for the hospital. SOR/2019-170, s. 11
Benzodiazepines and Other Targeted Substances Regulations — 64
Provision or administration to a patient 64 The person in charge of a hospital must not permit a targeted substance to be sold, provided or administered to a patient or animal under treatment as an in-patient or an out-patient of the hospital except pursuant to a prescription or other authorization of a practitioner practising in the hospital. SOR/2014-260, s. 37(F)
Benzodiazepines and Other Targeted Substances Regulations — 65
Supply to non-patients 65 (1) A pharmacist practising in a hospital or an individual who is authorized by the person in charge of a hospital to fill orders for targeted substances on behalf of the hospital may, on receipt of an order specifying the name, quantity and, if applicable, strength per unit of a targeted substance from any of the following persons, sell or provide the targeted substance to that person without a prescription: (a) subject to subsection (2), (i) a licensed dealer who (A) sold or provided the substance, or (B) is licensed to destroy targeted substances other than those that the licensed dealer produced, made, assembled, sold or provided, (ii) a practitioner, if the practitioner states that the substance is required because of a delay or shortfall in an order for the substance placed with a licensed dealer or pharmacist, (iii) a pharmacist, if the pharmacist states that the substance is required because of a delay or shortfall in an order for the substance placed with a licensed dealer, or (iv) another hospital, if the order is placed by a pharmacist practising in the other hospital or a practitioner who is authorized to order the targeted substance on behalf of the other hospital and the order states that the substance is required because of a delay or shortfall in an order placed with a licensed dealer or a pharmacist; (b) the Minister, if the order is a written order signed on the Minister’s behalf; and (c) a person to whom an exemption with respect to the targeted substance has been granted under section 56 of the Act, if (i) the person is an employee of or associated with the hospital, and (ii) the order is a written order accompanied by a copy of the exemption. Verbal orders (2) In the circumstances set out in paragraph (1)(a), if the order is verbal, the pharmacist practising in the hospital or the individual who is authorized by the person in charge of the hospital to fill orders for the targeted substance on behalf of the hospital must, before filling the order, record the following information: (a) the date on which the order was received; (b) the name and address of the person placing the order; (c) the brand name of the targeted substance or, if the targeted substance does not have a brand name, the specified name; (d) the quantity of the targeted substance ordered; and (e) their name. SOR/2019-170, s. 12(F)
Benzodiazepines and Other Targeted Substances Regulations — 66
Information 66 The person in charge of a hospital must record, or cause to be recorded, the following information: (a) the brand name or, if the targeted substance does not have a brand name, the specified name, the quantity of any targeted substance received by the hospital and the date on which it was received; (b) the name and address of the licensed dealer, pharmacist or other hospital that sold or provided the targeted substance; (c) the name and quantity of the targeted substance sold, provided, administered, sent, delivered or transported, the name and address of the recipient and the date of the transaction; and (d) the name and address of any out-patient to whom a targeted substance is sold or provided under section 64. SOR/2010-223, s. 30
Benzodiazepines and Other Targeted Substances Regulations — 67
Closure 67 If a targeted substance is stored in a hospital or the pharmacy department of a hospital and the hospital or department closes, the person in charge of the hospital must, not later than 10 days after the day of the closure, inform the Minister of the date of closure, the location to which the targeted substance was moved and the quantity of the targeted substance that was moved. SOR/2010-223, s. 31(E)
Benzodiazepines and Other Targeted Substances Regulations — 68
Importation — Canadian residents 68 (1) An individual who is a resident of Canada may, at the time of the individual’s return to Canada from a foreign country, import a targeted substance that is in their possession at the time of entry if (a) the substance has been obtained under a prescription and is labelled with the information set out in paragraphs 51(2)(a) to (g); (b) the individual is importing the substance (i) for their own use, (ii) for the use of a person for whom the individual is responsible and who is travelling with them, or (iii) for the use of an animal for which the individual is responsible and that is travelling with them; (c) the substance is imported to meet the medical needs of the individual or animal for whose benefit it is prescribed; (d) the substance is declared to a customs office at the port of entry into Canada at the time of import; and (e) the quantity being imported does not exceed the lesser of (i) a single course of treatment, and (ii) a 90-day supply, based on the usual daily dose. Importation — foreign residents (2) An individual who is a resident of a foreign country may, at the time that the individual enters Canada, import a targeted substance that is in their possession at the time of entry if (a) the requirements set out in paragraphs (1)(a) to (d) are met; and (b) the quantity imported is the least of (i) the content of the container, (ii) a 90-day supply, based on the usual daily dose, and (iii) the usual daily dose multiplied by the number of days that the individual will stay in Canada. SOR/2019-170, s. 14
Benzodiazepines and Other Targeted Substances Regulations — 69
Export 69 An individual may, at the time of their departure from Canada, export a targeted substance that is in their possession at the time of departure if (a) the substance has been obtained under a prescription and is labelled with the information set out in paragraphs 51(2)(a) to (g); (b) the individual is exporting the substance (i) for their own use, (ii) for the use of a person for whom the individual is responsible and who is travelling with them, or (iii) for the use of an animal for which the individual is responsible and that is travelling with them; (c) the substance is required to meet the medical needs of the individual or animal for whose benefit it is prescribed; and (d) the quantity exported does not exceed the lesser of (i) a single course of treatment, and (ii) a 90-day supply, based on the usual daily dose. SOR/2019-170, s. 15